ABVD vs. escBEACOPP in HL: a 10-year study
In the UK, escalated BEACOPP (escBEACOPP) was introduced as an alternative to ABVD for the treatment of advanced-stage Hodgkin lymphoma (HL). Here, George Follows, BMBCh, PhD, FRCP, FRCPath, of Cambri...
Author: VJHemOnc
Added: 02/09/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts